John Overdeck’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-35,671
Closed -$6.41M 3653
2017
Q3
$6.41M Buy
+35,671
New +$4.97M 0.02% 695
2017
Q2
Sell
-39,569
Closed -$3.11M 3494
2017
Q1
$3.11M Buy
+39,569
New +$2.45M 0.01% 1190

John Overdeck's KITE Position: Q4 2017 in Review

John Overdeck sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 35,671 shares — an estimated $6.41M sold.

John Overdeck first reported a position in KITE in Q1 2017 and held it in 2 quarters. The position peaked at $6.41M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • John Overdeck reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • John Overdeck sold 35,671 Kite Pharma, Inc. shares in Q4 2017, an estimated $6.41M.
  • John Overdeck first reported a position in Kite Pharma, Inc. in Q1 2017 and held it in 2 quarters.
  • John Overdeck's Kite Pharma, Inc. position peaked at $6.41M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Two Sigma Investments's 13F filing for Q4 2017, filed 14 Feb 2018.